Skip to content
10-Q

Quarterly Report

JOUNCE THERAPEUTICS, INC.

0001640455-22-000055

← back to feed
Filed
May 5, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 2, 2022 51.67M sh
Shares Diluted Q1 2022 · Mar 31, 2022 51.64M sh
Shares Diluted Q1 2022 · Mar 31, 2021 45.96M sh
Capex Q1 2022 · Mar 31, 2022 $107K
Capex Q1 2022 · Mar 31, 2021 $158K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$33.17M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$33.55M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $60.41M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $95.53M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $196.27M
Cash And Equivalents Q1 2022 · Dec 31, 2020 $147.49M
Stockholders Equity Q1 2022 · Mar 31, 2022 $188.96M
Stockholders Equity Q1 2022 · Dec 31, 2021 $223.81M
Stockholders Equity Q1 2022 · Mar 31, 2021 $279.45M
Stockholders Equity Q1 2022 · Dec 31, 2020 $211.29M
Current Liabilities Q1 2022 · Mar 31, 2022 $16.7M
Current Liabilities Q1 2022 · Dec 31, 2021 $18.9M
Total Liabilities Q1 2022 · Mar 31, 2022 $25.71M
Total Liabilities Q1 2022 · Dec 31, 2021 $28.89M
Current Assets Q1 2022 · Mar 31, 2022 $164.84M
Current Assets Q1 2022 · Dec 31, 2021 $190.83M
Total Assets Q1 2022 · Mar 31, 2022 $214.67M
Total Assets Q1 2022 · Dec 31, 2021 $252.7M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.72
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.58
Eps Basic Q1 2022 · Mar 31, 2022 −$0.72
Eps Basic Q1 2022 · Mar 31, 2021 −$0.58
Sga Expense Q1 2022 · Mar 31, 2022 $7.35M
Sga Expense Q1 2022 · Mar 31, 2021 $7.62M
Rd Expense Q1 2022 · Mar 31, 2022 $30.12M
Rd Expense Q1 2022 · Mar 31, 2021 $20.51M
Net Income Q1 2022 · Mar 31, 2022 −$37.37M
Net Income Q1 2022 · Mar 31, 2021 −$26.54M
Operating Income Q1 2022 · Mar 31, 2022 −$37.46M
Operating Income Q1 2022 · Mar 31, 2021 −$26.58M